Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT03994393
Title Non Small Cell Lung Cancer Trial of Durvalumab and Tremelimumab in Advanced Epidermal Growth Factor Receptor (EGFR) Mutant Disease. (ILLUMINATE)
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors University of Sydney
Age Groups: adult | senior
Covered Countries

No variant requirements are available.